Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member printed answering member label
tabling member	label

Search

385707

registered interest
date	25/06/2015
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Aircraft: Air Conditioning
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the Cranfield study on cabin air ever collected reliable information on the concentration of organophosphates in a visible fume event; and if so, what the quantitative figures collected were.
tabling member printed	The Countess of Mar
uin	HL831
answer	answer is ministerial correction date of answer 08/07/2015 answer text <p>The Cranfield University report of May 2011 successfully completed a range of air quality measurements during the course of 100 flights. Flight and cabin crew, as well as the investigating scientists reported a number of fume /smell events in a post-flight questionnaire. Samples specifically taken during recorded air quality events did not have notably elevated concentrations of any of the individually measured pollutants.</p><p> </p><p>Further detailed figures and measurements can be found in the Cranfield report.</p><p> </p> answering member printed Lord Ahmad of Wimbledon question first answered 08/07/2015 13:18:12 answering member 4210 label Biography information for Lord Ahmad of Wimbledon
tabling member	1861 label Biography information for The Countess of Mar

350104

registered interest
date	11/06/2015
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	West Africa: Ebola
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what has been the total cost so far of providing personnel from the Ministry of Defence, National Health Service and Public Health England, and materials and medicines from the United Kingdom, to international efforts to tackle the recent ebola crisis.
tabling member printed	The Countess of Mar
uin	HL418
answer	answer is ministerial correction date of answer 25/06/2015 answer text <p>The UK has committed £427m to combat Ebola in West Africa, £373m for the ongoing response and £54m for early recovery programmes. This package of support covers the cost of UK operations, including Ministry of Defence assets and personnel, PHE clinicians, materials and medicines. Over £260 million has now been disbursed.</p> answering member printed Earl of Courtown question first answered 25/06/2015 16:39:51 answering member 3359 label Biography information for The Earl of Courtown
tabling member	1861 label Biography information for The Countess of Mar

350105

registered interest
date	11/06/2015
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Prescribed Industrial Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many claims they have received for Prescribed Disease C3b in the last 10 years; and of these, how many were allowed.
tabling member printed	The Countess of Mar
uin	HL419
answer	answer is ministerial correction date of answer 18/06/2015 answer text <p /> <p>The information as requested is not available and could only be provided at disproportionate cost.</p> answering member printed Baroness Altmann question first answered 18/06/2015 13:40:56 answering member 4533 label Biography information for Baroness Altmann
tabling member	1861 label Biography information for The Countess of Mar

350106

registered interest
date	11/06/2015
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Sheep Dipping
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the statement by George Eustice, Minister of State, Department for Environment, Food and Rural Affairs, on 10 June (HC Deb, col 136WH), who published the 1991 Health and Safety Executive report of an inquiry into sheep dipping; and to whom it was distributed.
tabling member printed	The Countess of Mar
uin	HL420
answer	answer is ministerial correction date of answer 18/06/2015 answer text <p /> <p>The 1991 Health and Safety Executive (HSE) report presented the findings of a 1990 survey of sheep dipping and was published by HSE as an internal document in May 1991.</p><p> </p><p>The report was discussed at a meeting of the then Health and Safety Commission’s Agricultural Industry Advisory Committee (AIAC) working group, Chemicals In Agriculture (ChemAg), on 10 July 1991. The ChemAg working group membership included HSE, the Confederation of British Industry, the Trades Union Congress and other industry organisations.</p> answering member printed Baroness Altmann question first answered 18/06/2015 13:32:17 answering member 4533 label Biography information for Baroness Altmann
tabling member	1861 label Biography information for The Countess of Mar

347943

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, to date, how many adverse reactions to (1) Cervarix, (2) Gardasil and (3) generic human papilloma virus vaccines have been reported to the Medicines and Healthcare products Regulatory Agency; for each category, how many of those reports are of serious adverse reactions; and what age-specific rate those figures represent.
tabling member printed	The Countess of Mar
uin	HL229
answer	answer is ministerial correction date of answer 16/06/2015 answer text <p>A total of 8,243 suspected adverse drug reaction (ADR) reports with human papilloma virus (HPV) vaccines have been reported to the Medicines and Healthcare products Regulatory Agency (MHRA), via the Yellow Card Scheme, up to 3 June 2015.</p><p> </p><p> </p><p> </p><p>To date, more than 8 million doses of HPV vaccine have been given across the United Kingdom as part of the routine immunisation programme. The MHRA does not hold data on age-specific vaccine usage, and therefore age-specific reporting rates cannot be calculated.</p><p> </p><p> </p><p> </p><p>It is important to note that a Yellow Card report is not proof of a side effect occurring, but a suspicion by the reporter that the vaccine may have been the cause. Yellow Card data cannot be used as a reliable indicator of the frequency of suspected ADRs to vaccines or medicines. The level of ADR reporting may fluctuate between given years due to a variety of reasons such as a medicine being new (reporting rates are generally higher when a product is first introduced), stimulated interest/publicity and variations in exposure to the medicine.</p><p> </p><p> </p><p> </p><p>The possible known side effects, and the frequency, are listed in the product information which is provided with the vaccines. The vast majority of the 8,243 ADRs relate to the known risks of vaccination that are well-described in the available product information. The proportion of suspected ADRs for HPV vaccines that were reported as serious (32%) is less than the proportion reported as serious for other routinely used vaccines (68% overall) during the same time period. The expected benefits in protecting against HPV-related mortality and disease outweigh the known side effects of HPV vaccine.</p><p> </p><p> </p><p> </p><p>The following table provides a breakdown of UK suspected spontaneous ADRs received via the Yellow Card Scheme in association with the HPV vaccine. The MHRA does not hold data on age-specific vaccine usage, and therefore age-specific reporting rates cannot be calculated.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Vaccine Brand</p></td><td><p>Total number of reports</p></td><td><p>Number of serious reports (% of total)</p></td><td><p>Reporting rate per 1000 doses (serious reporting rates per 1000)</p></td></tr><tr><td><p>Cervarix</p></td><td><p>6,266</p></td><td><p>1,768 (28%)</p></td><td><p><ins class="ministerial">n/a **</ins><del class="ministerial">0.78 (0.22)</del></p></td></tr><tr><td><p>Gardasil</p></td><td><p>1,471</p></td><td><p>504 (34%)</p></td><td><p><ins class="ministerial">n/a **</ins><del class="ministerial">0.18 (0.06)</del></p></td></tr><tr><td><p>HPV Brand unspecified</p></td><td><p>507</p></td><td><p>326 (64%)</p></td><td><p><ins class="ministerial">n/a ** </ins><del class="ministerial">0.06 (0.04)</del></p></td></tr><tr><td><p>Total for Human Papilloma virus vaccines</p></td><td><p>*8,244</p></td><td><p>2,598 (32%)</p></td><td><p>1.03 (0.32)</p></td></tr></tbody></table><p> </p><p><em>Source:</em> MHRA sentinel database for adverse reactions.</p><p> </p><p>* It should be noted that the total number of reports received will not be equal to the totals in the table above as some reports of suspected adverse reactions may have included more than one vaccine.</p><p><ins class="ministerial">**Updated UK-wide brand-specific usage data are not available to MHRA at the time of writing based on a minimum of 8 million combined doses of Cervarix and Gardasil administered across the UK to date.</ins></p><p> </p><p><ins class="ministerial"> <p> </p><p> </p><p> </p></ins></p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The seriousness criteria for ADR reporting were determined by a working group of the Council for International Organizations of Medical Sciences (CIOMS) and are defined as 6 possible categories which are explained on the Yellow Card. The MHRA asks reporters to select one of the following criteria by ticking the appropriate box on the Yellow Card: (1) patient died due to reaction; (2) life threatening; (3) resulted in hospitalisation or prolonged inpatient hospitalisation; (4) congenital abnormality; and (5) involved persistent or significant disability or incapacity; or (6) if the reaction was deemed medically significant. In addition to this, seriousness of reaction terms has also been defined by the MHRA in its medical dictionary. Therefore an ADR report can be serious because the reporter considers the reaction to be serious or because the reaction term itself is considered serious in the MHRA medical dictionary.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 16/06/2015 14:35:02 question first ministerially corrected 03/07/2015 14:01:13 answering member 127 label Biography information for Lord Prior of Brampton previous answer version 5462 answering member printed Lord Prior of Brampton answering member 127 label Biography information for Lord Prior of Brampton
tabling member	1861 label Biography information for The Countess of Mar

228976

registered interest
date	23/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what will be the position of patients, previously served by a dispensing doctor practice, who live within 1.6 km of a pharmacy that closes, but still retains its licence, as a result of the closure of the Essential Small Pharmacies Scheme on 1 April 2015.
tabling member printed	The Countess of Mar
uin	HL5941
answer	answer is ministerial correction date of answer 25/03/2015 answer text <p>The ending of the essential small pharmacy local pharmaceutical services scheme on 31 March 2015 does not require such pharmacies to close. That is a decision for the individual contractor concerned. They may decide to return to the main National Health Service pharmaceutical list and come under the terms of the national community pharmacy contractual framework. Alternatively, they can decide to submit a proposal to NHS England to provide local pharmaceutical services. NHS England is working with individual providers of essential small pharmacies to ensure people in affected communities can continue to access appropriate NHS pharmaceutical services. However, if an essential small pharmacy – or any other type of pharmacy - did decide to close, it would no longer be able to provide NHS pharmaceutical services.</p><p> </p><p> </p><p> </p><p>Patients can at any time request in writing that a doctor provides them with NHS pharmaceutical services. Applications should be made via the doctor to the appropriate NHS England office. To be eligible to receive dispensing services from a doctor, a patient must meet certain criteria, such as having serious difficulty obtaining services from a pharmacy or the patient lives in a designated rural area, more than 1.6 kilometres from the nearest pharmacy. These criteria are set out in Regulation 48 of the National Health Services (Pharmaceutical Services and Local Pharmaceutical Services) Regulations 2013 – SI 2013/349. A patient must also be on the doctor’s patient list, or the patient list of the practice at which the doctor provides or performs primary medical services, and the practice must be authorised by NHS England to provide NHS dispensing services.</p><p> </p> answering member printed Earl Howe question first answered 25/03/2015 16:21:09 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar

226833

registered interest
date	11/03/2015
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Aircraft: Air Conditioning
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by the Parliamentary Under-Secretary of State for Transport, Robert Goodwill, on 4 March (HC225506), how many fume events occurred in flights observed by researchers conducting the Cranfield University study; whether the available health and safety standards and guidelines include the effects of pyrolised oil at temperatures exceeding 400 degrees Celsius in an enclosed space; and what assessment they have made of the advice from the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment that contaminated air is causing ill health but that they do not know the mechanism by which it has that effect.
tabling member printed	The Countess of Mar
uin	HL5627
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>A total of 38 flights had fumes or smells reported by at least one crew member or researcher during the Cranfield study. The Health and Safety Executive are responsible for introducing guidelines on health and safety at work legislation. However, the Cranfield study found that with respect to the conditions of flight that were experienced during the cabin air sampling, there was no evidence for pollutants occurring in cabin air at levels exceeding available health and safety standards and guidelines. The Committee on Toxicity (the COT) made a number of conclusions in their assessment. The Department welcomed these and forwarded the COT report to the European Aviation Safety Agency for their information.</p> answering member printed Baroness Kramer question first answered 17/03/2015 12:53:30 answering member 1557 label Biography information for Baroness Kramer
tabling member	1861 label Biography information for The Countess of Mar

226479

registered interest
date	10/03/2015
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Aircraft: Air Conditioning
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by the Parliamentary Under Secretary of State for Transport, Robert Goodwill, on 5 March (HC225928), what evidence is currently being reviewed by the Civil Aviation Authority in respect of the possibility of genetic factors which might influence individual susceptibility to environmental toxins.
tabling member printed	The Countess of Mar
uin	HL5601
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>The Civil Aviation Authority are reviewing the issue of genetic susceptibility to toxins in the context of documents provided by Dorset Coroner’s office.</p> answering member printed Baroness Kramer question first answered 17/03/2015 12:52:56 answering member 1557 label Biography information for Baroness Kramer
tabling member	1861 label Biography information for The Countess of Mar

224224

registered interest
date	27/02/2015
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Employment and Support Allowance
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the written statement by Lord Freud on 27 November 2014 (HLWS32), when they plan to bring forward the measure to prevent claimants being paid the Employment Support Allowance assessment rate if they have already been found fit for work but have made a repeat claim, and what consideration they have given to the implications this will have for disabled people and those with fluctuating conditions.
tabling member printed	The Countess of Mar
uin	HL5277
answer	answer is ministerial correction date of answer 11/03/2015 answer text <p /> <p>The Regulations that implement the measure making changes to how repeat claims for Employment and Support Allowance are dealt with were laid before Parliament on 5th March.</p><p> </p><p>The Regulations can be found at <a href="http://www.legislation.gov.uk/id/uksi/2015/437" target="_blank">http://www.legislation.gov.uk/id/uksi/2015/437</a>.</p><p> </p><p>The criteria for eligibility for the support group in Employment and Support Allowance remains the same for men and women.</p><p> </p><p>The updated guidance for healthcare professionals on the assessment of risk in claimants with a Mental Health condition was developed with input from senior psychiatrists. It differentiates between men and women in relation to suicide risk because the suicide rate in men is significantly higher than in women.</p><p> </p><p>The guidance makes clear that the assessment of risk needs to focus both on the claimant’s health and whether the claimant could cope with work-related activity.</p> answering member printed Lord Freud grouped question UIN HL5278 question first answered 11/03/2015 16:49:33 answering member 3893 label Biography information for Lord Freud
tabling member	1861 label Biography information for The Countess of Mar

224225

registered interest
date	27/02/2015
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Work Capability Assessment
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the scoring for Work Capability Assessment applicants with mental health problems has been loaded to make it more difficult for women to qualify for the support group than it is for men; and, if so, why.
tabling member printed	The Countess of Mar
uin	HL5278
answer	answer is ministerial correction date of answer 11/03/2015 answer text <p>The Regulations that implement the measure making changes to how repeat claims for Employment and Support Allowance are dealt with were laid before Parliament on 5th March.</p><p> </p><p>The Regulations can be found at <a href="http://www.legislation.gov.uk/id/uksi/2015/437" target="_blank">http://www.legislation.gov.uk/id/uksi/2015/437</a>.</p><p> </p><p>The criteria for eligibility for the support group in Employment and Support Allowance remains the same for men and women.</p><p> </p><p>The updated guidance for healthcare professionals on the assessment of risk in claimants with a Mental Health condition was developed with input from senior psychiatrists. It differentiates between men and women in relation to suicide risk because the suicide rate in men is significantly higher than in women.</p><p> </p><p>The guidance makes clear that the assessment of risk needs to focus both on the claimant’s health and whether the claimant could cope with work-related activity.</p> answering member printed Lord Freud grouped question UIN HL5277 question first answered 11/03/2015 16:49:33 answering member 3893 label Biography information for Lord Freud
tabling member	1861 label Biography information for The Countess of Mar